Elanco Animal Health (ELAN) Change in Acquisitions & Divestments (2020)
Elanco Animal Health (ELAN) posted Change in Acquisitions & Divestments of -$300000.0 for Q4 2020, down 103.75% sequentially from $8.0 million in Q2 2020.
Elanco Animal Health (ELAN) Change in Acquisitions & Divestments (2020) Analysis & Trends
Elanco Animal Health has reported Change in Acquisitions & Divestments for 1 years, with the latest figure at -$300000.0 in Q4 2020.
- Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to -$300000.0 in Q4 2020, while the trailing twelve-month figure through Sep 2021 was -$300000.0 (down 100.91% YoY) and the FY2020 annual result came in at $32.7 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments retreated to -$300000.0 in Q4 2020 per ELAN's latest filing, from $8.0 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $25.0 million in Q1 2020 and troughed at -$300000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.31 Bn | 39.66 Bn | 2.15 Bn |
| 3 | Zoetis | 31.65 Bn | 29.98 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.18 Bn | 19.52 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.94 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -300,000.00 |
| Dec 31, 2020 | -300,000.00 |
| Jun 30, 2020 | 8.00 Mn |
| Jun 30, 2020 | 8.00 Mn |
| Mar 31, 2020 | 25.00 Mn |
| Mar 31, 2020 | 25.00 Mn |